The current and future management of acute heart failure syndromes.
about
Ivabradine as adjuvant treatment for chronic heart failureNitrates for acute heart failure syndromesIvabradine as adjuvant treatment for chronic heart failureNutritional Deficiency in Patients with Heart FailureGlobal changes in the rat heart proteome induced by prolonged morphine treatment and withdrawalHeart failure in patients with normal coronary anatomy: diagnostic algorithm and disease pattern of various etiologies as defined by cardiac MRI.Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study.Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failureRapid evaluation by lung-cardiac-inferior vena cava (LCI) integrated ultrasound for differentiating heart failure from pulmonary disease as the cause of acute dyspnea in the emergency settingEvaluation of a provocative dyspnea severity score in acute heart failure.Heart failure in South America.Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failureTolvaptan for the treatment of heart failure: a review of the literature.Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes.Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC.Critical reappraisal of pulmonary artery catheterization and invasive hemodynamic assessment in acute heart failure.Treatment of acute heart failure in the emergency department.Vasopressin receptor antagonists: from pivotal trials to current practice.Hyperglycemia in acute heart failure: an opportunity to intervene?The role of intravenous vasodilators in acute heart failure management.Copeptin as a biomarker in heart failure.Editor's Choice- Call to action: Initiation of multidisciplinary care for acute heart failure begins in the Emergency Department.Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF).Creation and validation of the acute heart failure risk score: AHFRS.Prognostic Value of Urinary Neutrophil Gelatinase-Associated Lipocalin on the First Day of Admission for Adverse Events in Patients With Acute Decompensated Heart Failure.Spinal Neuronal NOS Signaling Contributes to Morphine Cardioprotection in Ischemia Reperfusion Injury in Rats.Unmasking the truth.A multicentre cohort study of acute heart failure syndromes in Korea: rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry.Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT).Clinical profiles in acute heart failure: one size fits all or not at all?Increasing self-knowledge: Utilizing tele-coaching for patients with congestive heart failure.Acute hyperglycemia and insulin resistance in acute heart failure syndromes without previously known diabetes.Clinical trials in acute heart failure: beginning of the end or end of the beginning?[Treatment of acute heart failure].Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction†A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial
P2860
Q24185982-3E54AFFA-6292-4AFC-9B3D-5BAA6A146FACQ24200550-12A2F5C0-8D9E-4762-82DE-2635718DDAE8Q24201614-C055A552-C5EF-484C-8578-8F1A9E3A7D76Q26741764-AA0D8200-E9FD-485B-BDA0-A798BF45DDA6Q28484293-26AD09B0-B753-4376-9EB7-D513EADDDD93Q30446792-EC43AAF0-486A-4489-AFFE-466BDD51370FQ34492056-9DD89766-1C08-4DC7-BD1F-3B9932181AA9Q35114953-21D06B5D-5747-4A1B-9CAD-445703CA357CQ36480294-8FB5307F-4BE0-42F4-9640-8DC17D13F241Q36564895-D485661B-3132-46CC-8CDB-158F7EF04B5FQ36928523-1D5D56D9-2601-45B3-8C09-E8E098C332B9Q37457781-89EF3BB0-89F7-4064-94CC-A42A56FE616CQ37852720-938E038D-2575-4171-AE92-885BEA69D6EDQ37889518-0FD891C8-6F3E-4B8D-8AD0-8AFD4974B336Q37895014-272B46FE-1F13-46AF-A546-75D8B947DF69Q38097505-80912998-DB1F-4EEF-8163-5B31008C51C7Q38145265-EF2D70B0-66AE-43B1-983A-B7CE5A877808Q38160378-797B0E68-AADF-456B-BEC6-88F0CF7872A4Q38217112-365EC8CC-C489-4B30-8704-914089012887Q38237577-3BBC9729-C40E-4E12-A8D0-B81F3DD37623Q38249996-FDAB4D38-FC9D-4E3E-A4ED-28DF9CB9BEA6Q38437103-EFC78891-C68C-40BF-82E4-D47BFD479137Q38689033-954B5776-8281-4036-AF62-B8CBC100FE3BQ39300538-FAFFC895-B590-47B5-8133-F03AAF403CFAQ41104212-AA1CD394-E33D-4011-A680-669018866204Q41150348-C6898AD7-92B9-4D29-B02E-710AB03C93F9Q41984203-BEAA8DE2-7C6B-4282-9998-80A34132FC4AQ43479728-3824595D-A17B-4D99-9425-5BAF3BAAD427Q43534981-A790CE29-DA9A-4DC6-8658-6DE9ACC25E8EQ47195489-855BFCAE-A4FF-4EED-B348-F6EA6F7E00B3Q50201301-294A00CB-60E7-4D1D-8183-DED268E70A09Q51373718-451141FB-8319-4D2A-ADD9-284EB33082D3Q53192175-15E482FB-3286-4937-BED4-185058B649D2Q53603789-82FE8748-C664-4297-A11B-6E344C123F4BQ57628656-5193B8CC-DDCD-40CA-A886-B068EE1345E6Q57628767-5552DC0C-1D79-4E79-9624-D69FD0095370
P2860
The current and future management of acute heart failure syndromes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The current and future management of acute heart failure syndromes.
@en
The current and future management of acute heart failure syndromes.
@nl
type
label
The current and future management of acute heart failure syndromes.
@en
The current and future management of acute heart failure syndromes.
@nl
prefLabel
The current and future management of acute heart failure syndromes.
@en
The current and future management of acute heart failure syndromes.
@nl
P2860
P356
P1476
The current and future management of acute heart failure syndromes.
@en
P2093
Peter S Pang
P2860
P304
P356
10.1093/EURHEARTJ/EHQ040
P577
2010-03-05T00:00:00Z